DOLUTEGRAVIR + LAMIVUDINE
dolutegravir 50 mg + lamivudine 300 mg tablet, 30
DOLUTEGRAVIR + LAMIVUDINE (11843H)
11843H
Manner of administration:Oral
Restriction 9987
Indication: HIV infection
Treatment phase: Initial treatment
Restriction 11066
Indication: HIV infection
Treatment phase: Continuing or change of treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $1,351.20 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Dovato | |||||